RU-28251

RU-28251
Clinical data
Other namesRU28251; 4,α-Methylene-N,N-dipropyltryptamine; 4,α-Methylene-DPT
Drug classDopamine receptor agonist; D2-like receptor agonist; Serotonin receptor modulator; Prolactin inhibitor
ATC code
  • None
Identifiers
  • N,N-dipropyl-1,3,4,5-tetrahydrobenzo[cd]indol-4-amine
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC17H24N2
Molar mass256.393 g·mol−1
3D model (JSmol)
  • CCCN(CCC)C1CC2=C3C(=CNC3=CC=C2)C1
  • InChI=1S/C17H24N2/c1-3-8-19(9-4-2)15-10-13-6-5-7-16-17(13)14(11-15)12-18-16/h5-7,12,15,18H,3-4,8-11H2,1-2H3
  • Key:YBHBWJNGSCDSMJ-UHFFFAOYSA-N

RU-28251, also known as 4,α-methylene-N,N-dipropyltryptamine (4,α-methylene-DPT), is a tricyclic cyclized tryptamine and simplified or partial ergoline. It is a dopamine D2-like receptor agonist and shows affinity for the serotonin 5-HT1 and 5-HT2 receptors (IC50Tooltip half-maximal inhibitory concentration = 141 nM and 723 nM, respectively). The drug inhibits prolactin secretion in animals. The chemical synthesis of RU-28251 has been described. RU-28251 was first described in the scientific literature by 1978.